alexa Infectious Diseases Conferences | Events | Meetings | USA | Europe | Middle East | 2016 | Conference Series LLC
Scientific Research and information

Make the best use of Researched information from 700+ peer reviewed, Open Access Journals operated by 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Meet Inspiring Speakers and Experts

Infectious Diseases Conferences

Share this page  Facebook  Twitter  LinkedIn  Google+  Pinterest   Blogger

Conference Series LLC in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , RetrovirusesFlu, HIV and Epidemiology

Market Analysis
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.

Conference Series LLC 
Conference Series LLC, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.

Conference Series LLC are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.

Scope& Importance
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.

The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.

 
Infection Congress 2017

Infection Congress 2017 is a nonpareil open platform is scheduled during May 11- 12, 2017 at Barcelona, Spain. This eminent event is going to through light with renowned speakers among Organizing Committee Members. It will be carried out with the title International Congress on Infectious Diseases and with the theme “Exploring recent outbreaks, advances & technologies in treatment & research of Infectious Diseases”. The organizing committee is gearing up for an exciting and informative conference program  this year also which includes plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. According to global data research and consulting firm the infectious diseases point-of-care testing (POCT) market is set to rise from $696.1 million in 2015 to just over $1.17 billion by 2022, represents a compound annual growth rate of 7.7%, which are top causes of environment-related deaths. The global data Analysis covering Medical Devices, explains the main barrier to the acceptability of infectious disease POC tests has been their relatively low accuracy.

Related Conferences:
35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, United States; Australasian Society for Infectious Diseases Annual Scientific Meeting, March 29 - April 1, 2017 Leura, Australia; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain; Annual Congress on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 Chicago, Illinois, USA; 2nd International conference on Flu, October 31- November 02, 2016 San Francisco, California, USA; International congress on Infectious Diseases, May11-12, 2017 Barcelona, Spain; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; 3rd International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada.

Bacteriology and Infectious Diseases Congress

Bacteriology and Infectious Diseases Congress will held amid May 25-26, 2017 Chicago, Illinois, USA giving a worldwide stage to research that bears new bits of knowledge into Microbiology, Molecular bacteriology, Clinical analytic bacteriology, Bacterial contaminations, Industrial bacteriology, Immunology and Infectious Diseases. Irresistible ailments are those which are brought on by microscopic organisms like E.coli, Salmonella, H.pylori, N.gonorrhoeae, N.meningitidis, S.aureus, and S.bacteria. It incorporates maladies like pneumonia, meningitis, gastroenteritis, urinary tract diseases. The medications used to treat such bacterial diseases are called Antibiotics. Particularly in US about $ 44.68 billion is relied upon to reach by 2016.In the time of 2005-2011, there is a development rate of 6.6% yearly. This aggregate is relied upon to develop from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound yearly development rate (CAGR) of 6.1% for the five-year time frame, 2013 to 2018.

Related Conferences: 
4th International Conference on Sexually Transmitted Diseases, Jun 19-20, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

STD 2017

STD 2017 is to be held amid June 19-20, 2017 London, UK, based upon subject Sexually transmitted maladies (STDs) are contaminations that can be seen when anybody having intercourse with somebody who has the disease. The reasons for STDs are microscopic organisms, parasites and infections, protozoans. There are more than 20 sorts of STDs. Sexually transmitted diseases influence both men and ladies, yet as a rule the wellbeing issues and their cause can be seen more serious in ladies. On the off chance that a pregnant lady has a STD, it can bring about genuine wellbeing issues for the infant. On the off chance that you have a STD brought on by microorganisms or parasites, your human services supplier can treat it with anti-infection agents or different prescriptions. On the off chance that you have a STD created by an infection, there is no cure. Once in a while pharmaceuticals can monitor the illness. Amend use of latex condoms enormously decreases, yet does not totally kill, the danger of getting or spreading STDs. The Centers for Disease Control and Prevention evaluates that in 2007, there were around 24,000 HIV-contaminated youth somewhere around 13 and 24 years old in the US. At present, HIV contamination is the seventh driving reason for death in this age bunch. Amid 2001–2004, in the 33 states with secret name-based HIV reporting, there were 17,824 people 13–24 years old with a conclusion of HIV/AIDS, of whom 62% were guys.

Related Conferences:
5th International Conference on HIV/AIDS, STDs & STIs, November 13-14, 2017 Las Vegas, USA; 3rd International Conference on Retroviruses and Novel Drugs, July 27-28, 2017; Non-Communicable Diseases and Therapies, November 16- 17, 2017 Las Vegas, USA; Vancouver, Canada; 4th World Congress on Infection Prevention and Control, November 13-15, 2017 Las Vegas, USA; STI & HIV World Congress Rio de Janeiro July 9-12, 2017; The annual Conference on Retroviruses and Opportunistic Infections (CROI) February 13–16, 2017; 26th Annual Canadian Conference on HIV/AIDS Research – CAHR 2017, April 6-9, 2017 in Montreal, Quebec; 9th IAS Conference on HIV Science (IAS 2017) 23-26 July 2017, Paris, France

Rare Disease Congress-2017

Conference series LLC to attend welcomes every intrigued possibility to attend the “3rd World Congress on Rare Diseases” which will be held amid June 29-30, 2017 in London, UK. The theme of this current year conference is “Novel Approaches to explore the emerging insights in the Rare Diseases Research”. Rare diseases, likewise alluded as orphan diseases, are portrayed by their low event with dominant part of them are serious chronically and life undermining. This Rare Disease Congress-2017 conference will serve as a method for imparting a more viable discourse on how the research world can address an overlooked rare disease. This intriguing occasion is sorted out to give an interesting stage to instructors, the scholarly world, new scientists from multiple disciplines, and learners from top universities to disseminate and discuss the upcoming innovations, potential outcomes in treatment of uncommon illnesses.

Related Conferences:
Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA;2nd International Conference on Flu, Oct 31- Nov 2, 2016 in San Francisco, USA;4th World Congress on Infection Prevention and Control, Nov 28-29, 2016 (9 Keynotes, 1 Special session, 2 Days,1 Event) Valencia, Spain; International congress on Infectious Diseases, May 11-12, 2017 Barcelona, Spain;5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 USA;4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan; International Conferences on Rare Diseases and Orphan Drugs Cape 19-22 Oct 2016, South Africa;19th International Conference on Infectious Diseases , Jan 26 - 27, 2017 Sydney Australia; Advances in Basic and Translational Research in Tropical Infectious Diseases ,Mar 12-17, 2017 Hotel Galvez Galveston, TX; Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada; 35th UC Davis Annual infectious diseases conference Feb 03-04, 2017 USA

Retroviruses 2017

Retroviruses 2017 will be scheduled during July 27-28, 2017 Vancouver, Canada brings together renowned experts from the international scientific community to provide a premier inter-multi-trans-disciplinary to exchange their latest results related to retroviral research, infections, rational drug designs and novel therapies and relevant fields to present their research at this exclusive scientific program .The theme of the Retroviruses 2017 is  Novel therapy and innovations for treatment of retroviruses  The Retroviruses Conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology, Infectious and Molecular Virology Diseases. The International and national agencies working in the AIDS research are The Joint United Nations Program on HIV/AIDS (UNAIDS), Australian AID (AusAID), British AID (DFID), US Government Assistance (USG), German AID (GTZ), Canadian Aboriginal AIDS Network (CAAN) International Labour Organization (ILO). More than 1.2 million people in the US are living with HIV, and 1 in 8 of them don’t know it.Over the last decade, the annual number of new HIV diagnoses declined 19%.Gay and bisexual men, particularly young African American gay and bisexual men, are most affected. African Americans continue to experience the greatest burden of HIV compared to other races and ethnicities. From 2005 to 2014: Diagnoses among all women declined 40%, and among African American women, diagnoses declined 42%. Among all heterosexuals, diagnoses declined 35%, and among people who inject drugs, diagnoses declined 63%. 

Related Conferences:
35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, United States; Australasian Society for Infectious Diseases Annual Scientific Meeting, March 29 - April 1, 2017 Leura, Australia; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain; Annual Congress on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 Chicago, Illinois, USA; 2nd International conference on Flu, October 31- November 02, 2016 San Francisco, California, USA; International congress on Infectious Diseases, May11-12, 2017 Barcelona, Spain; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada.

Influenza 2017

Influenza 2017 is sensing the raising importance of influenza and zoonotic disease prevention, control, treatment and cure, Conference Series Ltd will host during August 21-22, 2017 Birmingham, UK. The theme of Influenza 2017 is "Lower the Impact of Influenza on Public Health" Influenza 2017 offers a unique window and opportunities to present and evidence the latest updates with a holistic approach to different areas of interest. Our intention is, to create platforms which will gather eminent scientists, medical professionals who will undoubtedly enrich the conference. Global Influenza Market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. Similarly it has also been observed that 13 major zoonotic diseases which majorly include tuberculosis and bird flu are responsible for 2.2 million deaths globally every year. The global veterinary vaccines market is poised to reach USD 7.68 Billion by 2021 from USD 5.81 Billion in 2016, at a CAGR of 5.8% from 2016 to 2021. 

Related Conferences: 3rd  International Conference on Flu and Emerging Infectious Disease, Oct 30- Nov 1, 2017, Las Vegas, USA; 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30- Nov 1, 2017, San Antonio USA; 4th Euro-Global Conferences on Infectious Diseases, during September 07-09, 2017, Paris, France; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International congress on Infectious Diseases, May11-12, 2017 Barcelona, Spain; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada; 35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, USA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain.

Infectious Diseases

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of microbiology especially clinical and diagnostic microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. The conference attains significance when we look at the worldwide deaths due to Infectious Diseases like Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Related Conferences
5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Euro Infectious Diseases

Euro Infectious Diseases Conferences Sensing the raising importance of Infectious Diseases prevention, control, treatment and cure, Conference Series Ltd will host Euro Infectious Diseases Conference  scheduled from September 07-09, 2017 Paris, France, with a theme Preventing Emerging Infectious Diseases: New Strategy for the 21st Century.  World-renowned speakers, the most recent techniques, developments, and the newest updates in infectious diseases are hallmarks of this conference.  The conference provides an exceptional platform for the professionals who look beyond the clinical prospects. The Infectious Diseases market is poised to reach $18,156.2 million by 2019 from $12,422.8 million in 2014, at a CAGR of 7.9% from 2014 to 2019. Factors such as high prevalence rate of infectious diseases, increased demand for rapid diagnostic techniques due to slow turnaround time of current techniques, and the increase in government funding are driving market growth.
 
Related Conferences: 
4th International Congress on Infectious Diseasesduring May 11-12, 2017 in BarcelonaSpain. 5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs during June 19-20, 2017 in London, UK. 5th World Congress on Infectious Diseasesduring August 21-23, 2017 in San Francisco, California, USA.6th Euro-Global Conference on Infectious Diseases during September 07-09, 2017, at  Paris, France. 4th World Congress on Infection Prevention and Control during November 28-29, 2016 in Valencia, Spain.

Rare Diseases and Orphan Drugs

With the overwhelming success of the previous conference, “2nd Annual Congress on Rare Diseases and Orphan Drugs” is going to be held during October 30-November 1, 2017 in San Antonio, USA based upon theme “Platform to share new treatments and research for Rare Diseases”. Rare diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. The organizing committee is gearing up for an exciting and informative conference program including prompt keynote presentations, Oral talks, Poster presentations and Exhibitions which provides a  platform to discuss and learn about Rare Diseases, rare cancer, malignant glioma, Turner syndrome, Multiple myeloma, Renal cell carcinoma, Hepatocellular carcinoma, Morgellons , Diabetes in the young, Systemic Amyloidosis, Autoimmune diseases, Disorders of genetic origin, idiopathic disorders, rare genetic diseases, Orphan Drugs, Alzheimer’s Disease and many more. Right now drugs for rare diseases are the sweet spot of the biotechnology industry. Treatments for illnesses that affect only hundreds of patients can cost $200,000 or more and have built Genzyme into one of biotech’s biggest companies and Alexion and Biomarin into two of its hottest names for investors.

Related Conferences:
International Congress on Infectious Diseases May 11-12, 2017, Barcelona, Spain; 5th International Congress on Bacteriology and Infectious Diseases May 25-26, 2017, Chicago, USA; 3rd World Congress on Rare Diseases June 29-30, 2017, London, UK; 3rd International Conference on Retroviruses and Novel Drugs July 27-28, 2016, Vancouver, Canada; 4th Euro-Global Conference on Infectious Diseases September 7-9, 2017, Paris, France

Flu 2017

Flu 2017 will be scheduled during Oct 30-Nov 02, 2017, Las Vegas, USA. We have done our outmost to get rid of the traditional approach in the elaboration of the program and most importantly, during the active sessions, in order to foster innovation and scientific curiosity. The theme for Flu 2017 is “Understanding the Flu; Risk Analysis and Prevention”. The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years.

Related Conferences:
2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30- Nov 1, 2017, San Antonio USA; 4th Euro-Global Conferences on Infectious Diseases, during September 07-09, 2017, Paris, France; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain; 35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, USA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria.

Infection prevention and control

Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CDI, SSI, CRE, MRSA, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences. The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Related Conferences
3rd World Congress on Infectious Diseases, Aug 21-23, 2017 USA, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

 

Major Companies Related to Infectious Diseases